Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9228187 Antisense molecules and methods for treating pathologies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 16, 2013
Date of Patent
January 5, 2016
Patent Application Number
14108137
Patent Citations Received
‌
US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies
0
‌
US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 12005124 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
0
‌
US Patent 12064483 Nucleic acid-polypeptide compositions and methods of inducing exon skipping
0
‌
US Patent 12071621 Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
0
‌
US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 11679161 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
‌
US Patent 11771776 Muscle targeting complexes and uses thereof for treating dystrophinopathies
•••
Patent Inventor Names
Abbie Adams
0
Stephen Donald Wilton
0
Sue Fletcher
0
Penny Meloni
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9228187
Patent Primary Examiner
‌
Tracy Vivlemore

Find more entities like US Patent 9228187 Antisense molecules and methods for treating pathologies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo